Guideliner
Payments companies reported to CMS as associated with Guideliner. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Guideliner, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Guideliner
These are the largest totals companies reported as associated with Guideliner. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $82,431.10 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $26,024.95 |
| Craig Thompson | Hartford, CT | Interventional Cardiology | $25,852.01 |
| Saroj Neupane | Detroit, MI | Internal Medicine | $25,723.30 |
| William Nicholson | Atlanta, GA | Interventional Cardiology | $21,004.16 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $20,725.41 |
| Anthony Spaedy | Kansas City, KS | Interventional Cardiology | $18,707.30 |
| Scott Sharp | Indianapolis, IN | Interventional Cardiology | $9,846.40 |
| Emmanouil Brilakis | Minneapolis, MN | Interventional Cardiology | $5,750.00 |
| Khaldoon Alaswad | Detroit, MI | Interventional Cardiology | $4,709.44 |
Prescribed Guideliner?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.